BrainsWay Ltd. (BWAY:NASDAQ) closed at $11.25 on October 23, 2026, down 1.66% on the day. The stock trades 35.3% below its 52-week high of $17.40 and 57.7% above its 52-week low of $7.14. Over the past year, it gained 33.7%. BrainsWay Ltd. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 23, 2025, BWAY closed higher on 122 days (48%). Its best day was August 12, 2026 (+10.81%) and its worst was July 29, 2026 (-8.59%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 2 times.
Brainsway Ltd is an Israel based company engaged in the business of developing and providing advanced technology solutions for the treatment of a variety of brain disorders. Its flagship technology is based on Deep Transcranial Magnetic Stimulation (TMS) which is used for brain disorder treatment such as treatment of depression in patients. The group earns revenues from the sale and lease of devices. It has a business presence in Israel and other foreign countries.
Find more stocks like BWAY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.